OVARIAN SQUAMOUS CELL CARCINOMA
Clinical trials for OVARIAN SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy tested for Tough-to-Treat ovarian cancer
Disease control OngoingThis study is testing the immunotherapy drug pembrolizumab for women with advanced or recurrent ovarian squamous cell carcinoma that cannot be removed by surgery. The goal is to see if the drug can shrink tumors and help patients live longer. The trial will enroll 21 participants…
Matched conditions: OVARIAN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Niigata University Medical & Dental Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis large national trial is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control over 50 different types of rare cancers that have few or no standard treatment options. It enrolled over 800 adults whose rare cancers had progressed …
Matched conditions: OVARIAN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC